CALCIPOTRIENE

CALCIPOTRIENE was reported 3565 times

CALCIPOTRIENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IDIOPATHIC GUTTATE HYPOMELANOSIS 2 0.2222
1 RADIATION ALOPECIA 2 0.2000
2 SOCIAL (PRAGMATIC) COMMUNICATION DISORDER 6 0.0870
3 PENIS CARCINOMA 3 0.0789
4 MULTIPLE DRUG THERAPY 43 0.0570
5 FOLLICULAR DISORDER 2 0.0556
6 ACTINIC ELASTOSIS 4 0.0526
7 BENIGN FAMILIAL PEMPHIGUS 3 0.0462
8 EROSIVE PUSTULAR DERMATOSIS 2 0.0400
9 SENSORY PROCESSING DISORDER 6 0.0355
10 HAEMANGIOMA OF SKIN 12 0.0275
11 PULMONARY HILUM MASS 5 0.0266
12 LENTIGO 13 0.0262
13 KERATOSIS FOLLICULAR 2 0.0256
14 FINE MOTOR DELAY 6 0.0236
15 MULTIPLE DRUG HYPERSENSITIVITY 2 0.0208
16 SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED 5 0.0197
17 EAR DRYNESS 2 0.0190
18 KERATOACANTHOMA 13 0.0190
19 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 4 0.0190
20 GENITAL CANDIDIASIS 4 0.0188
21 POIKILODERMA 2 0.0185
22 MALIGNANT MELANOMA STAGE I 5 0.0184
23 POST POLIO SYNDROME 2 0.0179
24 AUTOIMMUNE LUNG DISEASE 2 0.0169
25 PHOTODERMATOSIS 7 0.0166
26 SEBORRHOEIC KERATOSIS 22 0.0151
27 GENITAL DISORDER 2 0.0149
28 BENIGN NEOPLASM OF SKIN 5 0.0148
29 GUTTATE PSORIASIS 12 0.0146
30 NAIL DYSTROPHY 8 0.0143
31 HLA-B*27 POSITIVE 2 0.0143
32 GENERALISED PUSTULAR PSORIASIS 4 0.0138
33 BONE METABOLISM DISORDER 4 0.0133
34 PRESBYACUSIS 4 0.0130
35 NAEVUS FLAMMEUS 2 0.0128
36 ARACHNOID CYST 5 0.0127
37 CANDIDA PNEUMONIA 4 0.0124
38 PIRIFORMIS SYNDROME 2 0.0118
39 FIBROUS HISTIOCYTOMA 4 0.0114
40 ALOPECIA SCARRING 2 0.0109
41 FALSE POSITIVE LABORATORY RESULT 2 0.0108
42 NAIL PITTING 4 0.0101
43 EXERCISE TOLERANCE DECREASED 57 0.0099
44 ADENOCARCINOMA METASTATIC 2 0.0097
45 BLOOD PRESSURE INADEQUATELY CONTROLLED 58 0.0096
46 BIRTH MARK 2 0.0096
47 PSEUDOCYST 3 0.0093
48 XEROSIS 10 0.0081
49 TINEA CRURIS 4 0.0080
50 SKIN PLAQUE 66 0.0078
51 PALMOPLANTAR PUSTULOSIS 4 0.0076
52 PAPULE 53 0.0075
53 STASIS DERMATITIS 5 0.0073
54 HEPATITIS B SURFACE ANTIGEN POSITIVE 2 0.0073
55 LICHENIFICATION 3 0.0073
56 DACTYLITIS 7 0.0071
57 POST INFLAMMATORY PIGMENTATION CHANGE 3 0.0066
58 NEOPLASM SKIN 10 0.0064
59 ECZEMA NUMMULAR 3 0.0061
60 MACULE 17 0.0061
61 ALCOHOLIC LIVER DISEASE 2 0.0059
62 SPINAL NERVE STIMULATOR IMPLANTATION 2 0.0059
63 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
64 PSORIASIS 742 0.0057
65 OESOPHAGEAL MOTILITY DISORDER 2 0.0056
66 INTERTRIGO 3 0.0055
67 NEUROLOGIC NEGLECT SYNDROME 3 0.0054
68 NASAL TURBINATE HYPERTROPHY 2 0.0053
69 B PRECURSOR TYPE ACUTE LEUKAEMIA 2 0.0052
70 ERYTHRODERMIC PSORIASIS 4 0.0049
71 SEBORRHOEIC DERMATITIS 8 0.0048
72 ONYCHOLYSIS 7 0.0045
73 ENTHESOPATHY 7 0.0045
74 POST-TRAUMATIC PAIN 2 0.0044
75 DERMATITIS PSORIASIFORM 9 0.0044
76 HEPATITIS FULMINANT 13 0.0044
77 MORPHOEA 2 0.0041
78 MELANOCYTIC NAEVUS 17 0.0039
79 DIABETES MELLITUS INADEQUATE CONTROL 67 0.0038
80 ANAEMIA MACROCYTIC 8 0.0037
81 EPHELIDES 2 0.0037
82 THERAPEUTIC PRODUCT INEFFECTIVE 14 0.0036
83 PRESBYOPIA 2 0.0036
84 TENOSYNOVITIS STENOSANS 2 0.0036
85 CAROTID ARTERY THROMBOSIS 3 0.0035
86 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
87 PSORIATIC ARTHROPATHY 139 0.0034
88 BLOOD ALBUMIN INCREASED 3 0.0034
89 ANOGENITAL WARTS 3 0.0034
90 MALIGNANT MELANOMA IN SITU 4 0.0032
91 DERMATOSIS 2 0.0032
92 SOLAR LENTIGO 3 0.0032
93 TINEA PEDIS 5 0.0031
94 LYMPHADENOPATHY MEDIASTINAL 6 0.0031
95 TELANGIECTASIA 3 0.0031
96 ACTINIC KERATOSIS 8 0.0031
97 POST PROCEDURAL SEPSIS 2 0.0030
98 MAMMOGRAM ABNORMAL 2 0.0030
99 HAND DERMATITIS 2 0.0029
100 DERMAL CYST 7 0.0028
101 MYOFASCIAL PAIN SYNDROME 2 0.0028
102 ACINETOBACTER INFECTION 3 0.0027
103 MENINGITIS ASEPTIC 12 0.0027
104 BENIGN NEOPLASM 3 0.0027
105 EXPOSURE TO COMMUNICABLE DISEASE 2 0.0027
106 ONYCHOCLASIS 18 0.0026
107 DIARRHOEA INFECTIOUS 2 0.0025
108 SKIN PAPILLOMA 10 0.0025
109 BLADDER PROLAPSE 3 0.0025
110 INFECTED BITE 2 0.0024
111 MYCOTIC ALLERGY 2 0.0023
112 LIPOMA 6 0.0023
113 RENAL TUBULAR ACIDOSIS 5 0.0023
114 ALOPECIA AREATA 4 0.0023
115 ACROCHORDON 3 0.0023
116 SKIN DISCOMFORT 6 0.0022
117 VULVOVAGINAL CANDIDIASIS 3 0.0022
118 OROPHARYNGEAL CANDIDIASIS 2 0.0022
119 LIGAMENT DISORDER 2 0.0022
120 SKIN DEPIGMENTATION 3 0.0022
121 HAEMATOCRIT INCREASED 5 0.0022
122 CALCIPHYLAXIS 4 0.0022
123 PRURIGO 2 0.0022
124 VITILIGO 5 0.0021
125 PUSTULE 5 0.0021
126 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 146 0.0021
127 CONJUNCTIVITIS ALLERGIC 3 0.0020
128 HYPERKERATOSIS 11 0.0020
129 VASODILATATION 5 0.0020
130 CONTRAINDICATION TO MEDICAL TREATMENT 3 0.0020
131 STOMA SITE HAEMORRHAGE 3 0.0019
132 ROSACEA 9 0.0019
133 POST LUMBAR PUNCTURE SYNDROME 2 0.0019
134 TEETH BRITTLE 2 0.0019
135 BONE DEMINERALISATION 2 0.0019
136 LIPODYSTROPHY ACQUIRED 4 0.0019
137 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
138 DIABETIC NEUROPATHY 9 0.0018
139 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
140 OPEN WOUND 2 0.0018
141 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
142 SKIN ABRASION 8 0.0017
143 SQUAMOUS CELL CARCINOMA OF SKIN 10 0.0017
144 OTITIS EXTERNA 2 0.0016
145 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
146 TACHYARRHYTHMIA 4 0.0016
147 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
148 SQUAMOUS CELL CARCINOMA 15 0.0016
149 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
150 DERMATITIS CONTACT 18 0.0016
151 ADJUSTMENT DISORDER 2 0.0015
152 SUSPECTED COVID-19 5 0.0015
153 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
154 PHARYNGEAL ULCERATION 2 0.0015
155 TREATMENT FAILURE 124 0.0015
156 PLANTAR FASCIITIS 5 0.0015
157 SHOULDER ARTHROPLASTY 4 0.0015
158 BREAST DISORDER 3 0.0015
159 SKIN EXFOLIATION 123 0.0015
160 PUSTULAR PSORIASIS 5 0.0015
161 SKIN HYPERTROPHY 4 0.0014
162 THERAPY NON-RESPONDER 63 0.0014
163 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
164 DEPRESSED MOOD 73 0.0014
165 DIVERTICULUM INTESTINAL 6 0.0014
166 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
167 IMPETIGO 2 0.0013
168 SKIN FISSURES 26 0.0013
169 REBOUND EFFECT 15 0.0013
170 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
171 SKIN LESION 36 0.0013
172 HAEMANGIOMA 3 0.0013
173 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
174 RASH VESICULAR 6 0.0012
175 COGNITIVE DISORDER 57 0.0012
176 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
177 SKIN INJURY 4 0.0012
178 MEAN CELL VOLUME INCREASED 3 0.0012
179 SKIN HYPERPIGMENTATION 10 0.0012
180 PERSONALITY DISORDER 3 0.0011
181 ROTATOR CUFF REPAIR 2 0.0011
182 SKIN HYPOPIGMENTATION 2 0.0011
183 ANIMAL BITE 3 0.0011
184 LARYNGOSPASM 3 0.0011
185 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
186 AUTISM SPECTRUM DISORDER 6 0.0011
187 PRODUCT DISTRIBUTION ISSUE 10 0.0011
188 ANAL HAEMORRHAGE 3 0.0011
189 MEDICATION ERROR 59 0.0011
190 SKIN WARM 6 0.0010
191 NAIL DISORDER 9 0.0010
192 PULMONARY PAIN 3 0.0010
193 NASAL SEPTUM DEVIATION 2 0.0010
194 METABOLIC ENCEPHALOPATHY 3 0.0010
195 CONTUSION 96 0.0010
196 MUCOSAL DRYNESS 2 0.0010
197 THERAPY PARTIAL RESPONDER 15 0.0010
198 BASAL CELL CARCINOMA 15 0.0010
199 TREATMENT NONCOMPLIANCE 52 0.0009
200 BREAST CANCER RECURRENT 3 0.0009
201 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
202 NEUROGENIC BLADDER 2 0.0009
203 AMNESIA 61 0.0009
204 ROTATOR CUFF SYNDROME 12 0.0009
205 INFUSION SITE BRUISING 2 0.0009
206 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
207 ONYCHOMYCOSIS 4 0.0009
208 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
209 COLONOSCOPY 2 0.0009
210 SKIN MASS 6 0.0009
211 BACTERIAL TEST POSITIVE 2 0.0009
212 MOBILITY DECREASED 64 0.0009
213 FEAR OF DEATH 2 0.0009
214 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
215 SKIN HAEMORRHAGE 13 0.0009
216 LICHENOID KERATOSIS 2 0.0009
217 ORAL PRURITUS 2 0.0009
218 SKIN ATROPHY 5 0.0009
219 CAROTID ARTERY STENOSIS 3 0.0009
220 ECONOMIC PROBLEM 13 0.0009
221 POOR QUALITY PRODUCT ADMINISTERED 9 0.0009
222 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0008
223 MYOPIA 2 0.0008
224 SINUS OPERATION 2 0.0008
225 PHARYNGITIS STREPTOCOCCAL 9 0.0008
226 PARADOXICAL DRUG REACTION 3 0.0008
227 CARTILAGE INJURY 2 0.0008
228 PIGMENTATION DISORDER 5 0.0008
229 OVARIAN CYST 8 0.0008
230 SNORING 3 0.0008
231 PARANASAL SINUS DISCOMFORT 3 0.0008
232 DERMATOMYOSITIS 2 0.0008
233 PARANASAL SINUS HYPERSECRETION 3 0.0008
234 GASTRIC INFECTION 3 0.0008
235 AORTIC ARTERIOSCLEROSIS 2 0.0008
236 TENDERNESS 8 0.0008
237 EXOSTOSIS 7 0.0008
238 WOUND SECRETION 3 0.0008
239 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
240 FOLLICULITIS 8 0.0008
241 JOINT STIFFNESS 20 0.0008
242 ANHEDONIA 20 0.0008
243 RADICULOPATHY 2 0.0008
244 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
245 INTRACRANIAL ANEURYSM 3 0.0007
246 JOINT RANGE OF MOTION DECREASED 10 0.0007
247 BURSITIS 9 0.0007
248 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
249 SINUS CONGESTION 10 0.0007
250 EAR CONGESTION 2 0.0007
251 APPLICATION SITE EXFOLIATION 3 0.0007
252 CYSTIC FIBROSIS 4 0.0007
253 ABDOMINAL DISCOMFORT 121 0.0007
254 COORDINATION ABNORMAL 10 0.0007
255 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
256 ANKLE FRACTURE 11 0.0007
257 JOINT LOCK 2 0.0007
258 PULMONARY TUBERCULOSIS 3 0.0007
259 NEOPLASM 8 0.0007
260 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
261 HYPERTONIC BLADDER 2 0.0007
262 OCULAR ICTERUS 3 0.0007
263 EYELID MARGIN CRUSTING 2 0.0007
264 HEPATIC CIRRHOSIS 13 0.0007
265 NODULE 9 0.0007
266 FAECES SOFT 5 0.0007
267 RASH PUSTULAR 5 0.0007
268 UTERINE LEIOMYOMA 5 0.0007
269 APPLICATION SITE PAIN 15 0.0007
270 STRIDOR 2 0.0007
271 WOUND 19 0.0007
272 GALLBLADDER DISORDER 12 0.0007
273 PULMONARY MASS 10 0.0007
274 DEVELOPMENTAL DELAY 6 0.0007
275 INJECTION SITE VESICLES 4 0.0007
276 HIDRADENITIS 6 0.0007
277 INJECTION SITE PAPULE 3 0.0007
278 BOWEL MOVEMENT IRREGULARITY 5 0.0007
279 NEPHROGENIC ANAEMIA 3 0.0006
280 RENAL FUNCTION TEST ABNORMAL 3 0.0006
281 MASS 9 0.0006
282 UMBILICAL HERNIA 3 0.0006
283 DRUG INEFFECTIVE 846 0.0006
284 PRODUCT USE IN UNAPPROVED INDICATION 159 0.0006
285 BLOOD CREATININE DECREASED 2 0.0006
286 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
287 INFUSION SITE PRURITUS 2 0.0006
288 NON-CARDIAC CHEST PAIN 2 0.0006
289 RASH PRURITIC 34 0.0006
290 SENSORY LOSS 5 0.0006
291 DERMATITIS 13 0.0006
292 APPLICATION SITE VESICLES 4 0.0006
293 HERPES SIMPLEX 4 0.0006
294 HORMONE LEVEL ABNORMAL 3 0.0006
295 HEPATIC NEOPLASM 2 0.0006
296 LYMPHOCYTE COUNT INCREASED 2 0.0006
297 PRODUCT DOSE OMISSION 40 0.0006
298 POLYP 4 0.0006
299 DEAFNESS NEUROSENSORY 2 0.0006
300 PERIPHERAL SWELLING 93 0.0006
301 MALIGNANT MELANOMA 8 0.0006
302 ERYSIPELAS 3 0.0006
303 QUALITY OF LIFE DECREASED 8 0.0006
304 BRONCHIECTASIS 4 0.0006
305 MOTOR DYSFUNCTION 6 0.0006
306 CERVICAL VERTEBRAL FRACTURE 2 0.0006
307 DEVICE DEFECTIVE 10 0.0006
308 ECZEMA 30 0.0006
309 SPINAL OSTEOARTHRITIS 5 0.0006
310 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
311 SKIN IRRITATION 26 0.0006
312 OEDEMA PERIPHERAL 69 0.0006
313 RASH ERYTHEMATOUS 27 0.0006
314 SCIATICA 9 0.0006
315 APPENDICECTOMY 2 0.0006
316 PRODUCT SUPPLY ISSUE 4 0.0006
317 OVERWEIGHT 3 0.0006
318 SKIN LACERATION 6 0.0006
319 LUPUS-LIKE SYNDROME 5 0.0006
320 PRODUCT PRESCRIBING ISSUE 12 0.0006
321 SINUSITIS 56 0.0005
322 THROMBOCYTOSIS 2 0.0005
323 NERVE COMPRESSION 5 0.0005
324 SKIN DISORDER 18 0.0005
325 IMMUNODEFICIENCY 8 0.0005
326 SUNBURN 4 0.0005
327 CHRONIC SINUSITIS 2 0.0005
328 ORAL CANDIDIASIS 7 0.0005
329 CLAVICLE FRACTURE 2 0.0005
330 GINGIVAL DISORDER 2 0.0005
331 FOOD ALLERGY 4 0.0005
332 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
333 TENDONITIS 8 0.0005
334 APHTHOUS ULCER 4 0.0005
335 MUSCLE RUPTURE 2 0.0005
336 FUNGAL INFECTION 17 0.0005
337 NAIL DISCOLOURATION 2 0.0005
338 DRUG ERUPTION 9 0.0005
339 ARTHRALGIA 211 0.0005
340 GANGRENE 3 0.0005
341 HEPATITIS B 3 0.0005
342 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
343 POST PROCEDURAL INFECTION 4 0.0005
344 LEG AMPUTATION 2 0.0005
345 SPINAL STENOSIS 2 0.0005
346 PHOTOSENSITIVITY REACTION 8 0.0005
347 PRURITUS 185 0.0005
348 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
349 HEMIPLEGIA 4 0.0005
350 MULTIPLE INJURIES 3 0.0005
351 CELLULITIS 24 0.0005
352 DISCOMFORT 29 0.0005
353 CANDIDA INFECTION 8 0.0005
354 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
355 SLEEP APNOEA SYNDROME 9 0.0005
356 ENTERITIS 3 0.0005
357 TENSION HEADACHE 2 0.0005
358 ERYTHEMA 95 0.0005
359 SKIN SWELLING 4 0.0005
360 CHRONIC KIDNEY DISEASE 35 0.0005
361 RASH 200 0.0005
362 APPLICATION SITE ERYTHEMA 12 0.0005
363 INSURANCE ISSUE 7 0.0005
364 RASH MACULAR 16 0.0005
365 TONGUE DISCOLOURATION 2 0.0005
366 PARONYCHIA 2 0.0005
367 SARS-COV-2 TEST POSITIVE 6 0.0005
368 LIGAMENT RUPTURE 2 0.0005
369 MIGRAINE 43 0.0004
370 RHINITIS ALLERGIC 2 0.0004
371 HYPERTENSION 95 0.0004
372 BREAST MASS 3 0.0004
373 RASH PAPULAR 10 0.0004
374 SKIN INFECTION 5 0.0004
375 PAIN OF SKIN 12 0.0004
376 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
377 PAPILLOEDEMA 2 0.0004
378 PRODUCT DOSE OMISSION ISSUE 129 0.0004
379 HAEMOGLOBIN INCREASED 2 0.0004
380 SCAB 5 0.0004
381 DERMATITIS ATOPIC 23 0.0004
382 DROOLING 3 0.0004
383 LARGE INTESTINE POLYP 3 0.0004
384 ARTHRITIS 34 0.0004
385 CONJUNCTIVITIS 8 0.0004
386 ARTHRITIS INFECTIVE 2 0.0004
387 ROAD TRAFFIC ACCIDENT 18 0.0004
388 GASTRITIS EROSIVE 2 0.0004
389 FEELING OF DESPAIR 2 0.0004
390 NEPHROPATHY 4 0.0004
391 DIARRHOEA HAEMORRHAGIC 4 0.0004
392 SKIN TIGHTNESS 2 0.0004
393 HYPERSOMNIA 12 0.0004
394 HYPERLIPIDAEMIA 5 0.0004
395 IMPAIRED QUALITY OF LIFE 6 0.0004
396 PARAESTHESIA ORAL 6 0.0004
397 ENTEROCOCCAL INFECTION 2 0.0004
398 THERAPEUTIC RESPONSE DECREASED 25 0.0004
399 MOUTH HAEMORRHAGE 3 0.0004
400 FREQUENT BOWEL MOVEMENTS 11 0.0004
401 INFLAMMATION 21 0.0004
402 SENSITIVE SKIN 3 0.0004
403 HYPOPHOSPHATAEMIA 3 0.0004
404 FOOT OPERATION 2 0.0004
405 OSTEOARTHRITIS 17 0.0004
406 DERMATITIS EXFOLIATIVE 2 0.0004
407 CORONARY ARTERY STENOSIS 2 0.0004
408 OSTEOPENIA 6 0.0004
409 MUSCLE ATROPHY 5 0.0004
410 AORTIC ANEURYSM 3 0.0004
411 HIP ARTHROPLASTY 6 0.0004
412 SKIN DISCOLOURATION 18 0.0004
413 ENDOCARDITIS 2 0.0004
414 OSTEOPOROSIS 16 0.0004
415 LIMB DISCOMFORT 12 0.0004
416 SKIN ULCER 10 0.0004
417 BRAIN FOG 6 0.0004
418 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
419 RENAL CYST 3 0.0004
420 RESPIRATORY TRACT CONGESTION 6 0.0004
421 GINGIVAL PAIN 3 0.0004
422 SKIN BURNING SENSATION 27 0.0004
423 EAR INFECTION 10 0.0004
424 DRY SKIN 50 0.0004
425 BODY HEIGHT DECREASED 4 0.0004
426 HIP SURGERY 2 0.0004
427 NORMAL NEWBORN 2 0.0004
428 PRODUCT USE ISSUE 69 0.0004
429 NONSPECIFIC REACTION 2 0.0004
430 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
431 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
432 EXPIRED PRODUCT ADMINISTERED 12 0.0004
433 ARTHROPATHY 20 0.0004
434 STREPTOCOCCAL INFECTION 2 0.0004
435 ORAL HERPES 7 0.0004
436 SNEEZING 8 0.0004
437 PANIC ATTACK 13 0.0004
438 PERIORBITAL SWELLING 2 0.0004
439 SINUS DISORDER 7 0.0004
440 SEASONAL ALLERGY 5 0.0004
441 SWOLLEN TONGUE 11 0.0004
442 PERONEAL NERVE PALSY 2 0.0004
443 VITAMIN D DECREASED 3 0.0004
444 HERPES VIRUS INFECTION 2 0.0003
445 HYSTERECTOMY 3 0.0003
446 HYPERTHYROIDISM 5 0.0003
447 RALES 2 0.0003
448 MOVEMENT DISORDER 11 0.0003
449 MUSCULOSKELETAL STIFFNESS 30 0.0003
450 SPLENOMEGALY 4 0.0003
451 DIARRHOEA 220 0.0003
452 BLISTER 19 0.0003
453 CATARACT OPERATION 2 0.0003
454 MYALGIA 57 0.0003
455 GASTROINTESTINAL INFECTION 3 0.0003
456 GOUT 6 0.0003
457 SYMPTOM RECURRENCE 2 0.0003
458 PLATELET COUNT ABNORMAL 2 0.0003
459 LOCALISED INFECTION 8 0.0003
460 OPTIC NEURITIS 3 0.0003
461 ILLNESS 34 0.0003
462 INGUINAL HERNIA 2 0.0003
463 NO THERAPEUTIC RESPONSE 4 0.0003
464 NEPHROLITHIASIS 15 0.0003
465 RETINAL DETACHMENT 3 0.0003
466 MENISCUS INJURY 2 0.0003
467 POOR QUALITY SLEEP 7 0.0003
468 SKIN CANCER 7 0.0003
469 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
470 JOINT SWELLING 39 0.0003
471 MUSCULOSKELETAL CHEST PAIN 5 0.0003
472 PHARYNGITIS 4 0.0003
473 OLIGURIA 2 0.0003
474 PNEUMONIA ASPIRATION 8 0.0003
475 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
476 NASAL DRYNESS 2 0.0003
477 LACERATION 3 0.0003
478 INFUSION SITE SWELLING 2 0.0003
479 PRODUCT COMPLAINT 8 0.0003
480 SCREAMING 2 0.0003
481 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
482 AFFECT LABILITY 3 0.0003
483 PAIN 191 0.0003
484 LYMPHADENOPATHY 11 0.0003
485 RHINORRHOEA 20 0.0003
486 AUTOIMMUNE DISORDER 3 0.0003
487 INFLAMMATORY BOWEL DISEASE 3 0.0003
488 NASAL CONGESTION 18 0.0003
489 RENAL TUBULAR NECROSIS 3 0.0003
490 HEPATOMEGALY 3 0.0003
491 HOSPICE CARE 3 0.0003
492 TOOTH INFECTION 4 0.0003
493 LIGAMENT SPRAIN 3 0.0003
494 STAPHYLOCOCCAL INFECTION 10 0.0003
495 DRUG EFFECT INCOMPLETE 11 0.0003
496 CORONAVIRUS INFECTION 2 0.0003
497 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
498 SLEEP DISORDER 21 0.0003
499 DRY MOUTH 24 0.0003
500 THROAT TIGHTNESS 8 0.0003
501 PRODUCT LABEL ISSUE 2 0.0003
502 TOOTH ABSCESS 3 0.0003
503 ABNORMAL LOSS OF WEIGHT 2 0.0003
504 SCAR 5 0.0003
505 INJECTION SITE WARMTH 6 0.0003
506 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
507 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
508 DIVERTICULITIS 8 0.0003
509 CARPAL TUNNEL SYNDROME 4 0.0003
510 INJECTION SITE DISCOMFORT 3 0.0003
511 SCRATCH 3 0.0003
512 APPLICATION SITE REACTION 2 0.0003
513 HEADACHE 177 0.0003
514 LIVER FUNCTION TEST INCREASED 6 0.0003
515 DRUG EFFECT DECREASED 15 0.0003
516 BIPOLAR DISORDER 3 0.0003
517 MAJOR DEPRESSION 2 0.0003
518 BLINDNESS TRANSIENT 2 0.0003
519 RASH GENERALISED 7 0.0003
520 VENTRICULAR FIBRILLATION 3 0.0003
521 NERVE INJURY 3 0.0003
522 GAIT INABILITY 9 0.0003
523 NECK PAIN 15 0.0003
524 NASOPHARYNGITIS 49 0.0003
525 HEPATIC FAILURE 8 0.0003
526 PEMPHIGOID 2 0.0003
527 LACRIMATION INCREASED 8 0.0003
528 EMOTIONAL DISTRESS 32 0.0003
529 TENDON PAIN 2 0.0003
530 BLOOD URINE PRESENT 5 0.0003
531 INFECTION 38 0.0003
532 PULMONARY FIBROSIS 5 0.0003
533 POST PROCEDURAL COMPLICATION 5 0.0003
534 GLAUCOMA 5 0.0003
535 BLOOD BILIRUBIN INCREASED 7 0.0003
536 HERNIA 5 0.0003
537 GASTROINTESTINAL INFLAMMATION 2 0.0003
538 AFFECTIVE DISORDER 2 0.0003
539 FURUNCLE 2 0.0003
540 HALLUCINATION, AUDITORY 4 0.0003
541 ULCER 4 0.0003
542 OBESITY 4 0.0003
543 WRIST FRACTURE 3 0.0003
544 CONDITION AGGRAVATED 76 0.0002
545 BACK PAIN 58 0.0002
546 BLOOD DISORDER 2 0.0002
547 DRUG INTOLERANCE 24 0.0002
548 MYASTHENIA GRAVIS 2 0.0002
549 FRUSTRATION TOLERANCE DECREASED 2 0.0002
550 FIBROMYALGIA 6 0.0002
551 NEURALGIA 6 0.0002
552 NAUSEA 195 0.0002
553 BLOOD POTASSIUM INCREASED 4 0.0002
554 MUSCLE SPASTICITY 3 0.0002
555 ABNORMAL FAECES 2 0.0002
556 IMPAIRED HEALING 8 0.0002
557 SPINAL OPERATION 3 0.0002
558 HYPERCALCAEMIA 3 0.0002
559 BURNING SENSATION 17 0.0002
560 EYE SWELLING 9 0.0002
561 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
562 DRY EYE 12 0.0002
563 EOSINOPHIL COUNT INCREASED 2 0.0002
564 SECRETION DISCHARGE 3 0.0002
565 DERMATITIS ALLERGIC 3 0.0002
566 INFUSION SITE ERYTHEMA 2 0.0002
567 HEMIPARESIS 4 0.0002
568 INJECTION SITE IRRITATION 3 0.0002
569 CIRCULATORY COLLAPSE 4 0.0002
570 MYDRIASIS 3 0.0002
571 PRODUCT CONTAINER ISSUE 2 0.0002
572 PSEUDOMONAS INFECTION 2 0.0002
573 IRRITABLE BOWEL SYNDROME 5 0.0002
574 RECTAL HAEMORRHAGE 10 0.0002
575 MUSCLE STRAIN 2 0.0002
576 CARDIAC MURMUR 2 0.0002
577 DIPLOPIA 6 0.0002
578 PYELONEPHRITIS 2 0.0002
579 PALPITATIONS 27 0.0002
580 RESPIRATORY TRACT INFECTION 6 0.0002
581 PLATELET COUNT INCREASED 3 0.0002
582 BRONCHITIS 17 0.0002
583 BLOOD PRESSURE INCREASED 35 0.0002
584 BLOOD CALCIUM INCREASED 2 0.0002
585 COVID-19 40 0.0002
586 IMMUNE SYSTEM DISORDER 3 0.0002
587 ANKYLOSING SPONDYLITIS 3 0.0002
588 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
589 IMMUNOSUPPRESSION 2 0.0002
590 PURPURA 2 0.0002
591 FACIAL PAIN 2 0.0002
592 ADVERSE DRUG REACTION 20 0.0002
593 LOSS OF LIBIDO 2 0.0002
594 ANAL INCONTINENCE 2 0.0002
595 GASTROENTERITIS VIRAL 4 0.0002
596 OEDEMA 12 0.0002
597 LEUKOCYTOSIS 4 0.0002
598 PAIN IN EXTREMITY 65 0.0002
599 APPLICATION SITE PRURITUS 5 0.0002
600 END STAGE RENAL DISEASE 4 0.0002
601 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
602 IRON DEFICIENCY ANAEMIA 2 0.0002
603 ERYTHEMA MULTIFORME 2 0.0002
604 DEFORMITY 2 0.0002
605 BLOOD TEST ABNORMAL 3 0.0002
606 SKIN REACTION 3 0.0002
607 SINUS TACHYCARDIA 3 0.0002
608 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
609 URINARY TRACT INFECTION 36 0.0002
610 RED BLOOD CELL COUNT DECREASED 6 0.0002
611 PARALYSIS 3 0.0002
612 HYPOACUSIS 9 0.0002
613 INSOMNIA 55 0.0002
614 INFLUENZA 23 0.0002
615 OFF LABEL USE 180 0.0002
616 DYSSTASIA 6 0.0002
617 HAEMORRHOIDS 4 0.0002
618 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
619 KNEE OPERATION 2 0.0002
620 WHEEZING 12 0.0002
621 CATARACT 12 0.0002
622 COLON CANCER 3 0.0002
623 GASTROINTESTINAL DISORDER 18 0.0002
624 RESPIRATORY DISORDER 6 0.0002
625 INJECTION SITE BRUISING 16 0.0002
626 SWELLING FACE 13 0.0002
627 EMPHYSEMA 2 0.0002
628 INTENTIONAL SELF-INJURY 4 0.0002
629 ACNE 15 0.0002
630 DRY THROAT 2 0.0002
631 FATIGUE 153 0.0002
632 SUBARACHNOID HAEMORRHAGE 2 0.0002
633 TINNITUS 9 0.0002
634 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
635 EUPHORIC MOOD 2 0.0002
636 INITIAL INSOMNIA 2 0.0002
637 ABDOMINAL PAIN UPPER 40 0.0002
638 DEPRESSION 44 0.0002
639 CARDIAC DISORDER 18 0.0002
640 HERPES ZOSTER 11 0.0002
641 MUSCULOSKELETAL PAIN 10 0.0002
642 HEPATIC ENZYME INCREASED 13 0.0002
643 DYSURIA 7 0.0002
644 KNEE ARTHROPLASTY 4 0.0002
645 NEUROPATHY PERIPHERAL 18 0.0002
646 RENAL PAIN 2 0.0002
647 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
648 ABSCESS 3 0.0002
649 EATING DISORDER 4 0.0002
650 CHILLS 22 0.0002
651 SURGERY 11 0.0002
652 DRUG DOSE OMISSION 31 0.0002
653 LOSS OF CONSCIOUSNESS 24 0.0002
654 VOMITING 88 0.0002
655 IMPAIRED WORK ABILITY 4 0.0002
656 HEREDITARY ANGIOEDEMA 2 0.0002
657 WEIGHT DECREASED 52 0.0002
658 COUGH 52 0.0002
659 DECREASED ACTIVITY 2 0.0002
660 MUSCLE TIGHTNESS 3 0.0002
661 DEVICE MALFUNCTION 13 0.0002
662 ATRIAL FIBRILLATION 18 0.0002
663 BACK DISORDER 3 0.0002
664 DYSPEPSIA 18 0.0002
665 ASPIRATION 2 0.0002
666 THERAPY INTERRUPTED 13 0.0002
667 GASTROINTESTINAL PAIN 2 0.0002
668 PROCEDURAL PAIN 5 0.0002
669 LIP SWELLING 6 0.0002
670 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
671 BLOOD UREA INCREASED 3 0.0002
672 MALNUTRITION 2 0.0002
673 ANXIETY 50 0.0002
674 PRODUCT AVAILABILITY ISSUE 4 0.0002
675 INTENTIONAL DOSE OMISSION 5 0.0002
676 INJECTION SITE HAEMORRHAGE 14 0.0002
677 MICTURITION URGENCY 2 0.0002
678 GASTRIC DISORDER 6 0.0002
679 ABORTION SPONTANEOUS 7 0.0002
680 INJECTION SITE REACTION 12 0.0002
681 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
682 HYPERSENSITIVITY 32 0.0002
683 SPINAL PAIN 2 0.0002
684 INFLUENZA LIKE ILLNESS 14 0.0002
685 ASCITES 5 0.0002
686 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
687 LABORATORY TEST ABNORMAL 5 0.0002
688 INJECTION SITE ERYTHEMA 21 0.0002
689 OCULAR HYPERAEMIA 8 0.0002
690 PRODUCT PRESCRIBING ERROR 4 0.0002
691 CHOLECYSTITIS 2 0.0002
692 PRODUCTIVE COUGH 8 0.0002
693 MACULAR DEGENERATION 2 0.0002
694 DIABETIC KETOACIDOSIS 4 0.0002
695 HEPATITIS C 2 0.0002
696 APHASIA 5 0.0002
697 PELVIC PAIN 3 0.0002
698 CORONARY ARTERY DISEASE 5 0.0002
699 RESTLESS LEGS SYNDROME 3 0.0002
700 NEOPLASM MALIGNANT 11 0.0002
701 ADRENAL INSUFFICIENCY 2 0.0002
702 NOCTURIA 2 0.0002
703 ACUTE KIDNEY INJURY 25 0.0002
704 ABDOMINAL PAIN 38 0.0002
705 FEELING HOT 10 0.0002
706 HAEMATOCHEZIA 9 0.0002
707 INJECTION SITE URTICARIA 4 0.0002
708 LIVER INJURY 4 0.0002
709 ALOPECIA 32 0.0002
710 INJECTION SITE MASS 6 0.0002
711 OROPHARYNGEAL PAIN 15 0.0002
712 TENDON RUPTURE 2 0.0002
713 ABNORMAL WEIGHT GAIN 2 0.0002
714 THROMBOSIS 13 0.0002
715 GENERALISED OEDEMA 2 0.0002
716 CYST 2 0.0002
717 BACTERIAL INFECTION 3 0.0002
718 MEMORY IMPAIRMENT 22 0.0002
719 DYSARTHRIA 6 0.0002
720 DRUG-INDUCED LIVER INJURY 5 0.0002
721 FEELING ABNORMAL 38 0.0002
722 COLITIS 6 0.0002
723 LIVER DISORDER 7 0.0002
724 GASTRIC ULCER 3 0.0002
725 PROTEINURIA 3 0.0002
726 CYSTITIS 5 0.0002
727 DEVICE DEPLOYMENT ISSUE 2 0.0002
728 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
729 DEVICE ISSUE 14 0.0002
730 ACUTE RESPIRATORY FAILURE 3 0.0002
731 INFUSION SITE PAIN 2 0.0002
732 NIGHT SWEATS 5 0.0002
733 HIATUS HERNIA 2 0.0002
734 PNEUMONIA 50 0.0002
735 NERVOUSNESS 8 0.0002
736 PARAESTHESIA 24 0.0002
737 ADVERSE EVENT 14 0.0002
738 PULMONARY CONGESTION 2 0.0002
739 HAEMATOCRIT DECREASED 3 0.0002
740 BLOOD PRESSURE ABNORMAL 3 0.0002
741 BRADYCARDIA 8 0.0002
742 ADVERSE REACTION 2 0.0002
743 UPPER LIMB FRACTURE 3 0.0002
744 INJECTION SITE PAIN 46 0.0001
745 SWELLING 14 0.0001
746 HAIR TEXTURE ABNORMAL 2 0.0001
747 FULL BLOOD COUNT DECREASED 3 0.0001
748 PRODUCT STORAGE ERROR 13 0.0001
749 TASTE DISORDER 3 0.0001
750 ANGER 5 0.0001
751 IMPAIRED GASTRIC EMPTYING 2 0.0001
752 CORONARY ARTERY OCCLUSION 2 0.0001
753 CHEST PAIN 27 0.0001
754 VISUAL IMPAIRMENT 18 0.0001
755 DIABETES MELLITUS 11 0.0001
756 FEELING COLD 4 0.0001
757 RENAL FAILURE 19 0.0001
758 HEART RATE DECREASED 5 0.0001
759 MOUTH ULCERATION 3 0.0001
760 DEVICE OCCLUSION 2 0.0001
761 SUICIDAL IDEATION 13 0.0001
762 HYPOXIA 5 0.0001
763 PAIN IN JAW 4 0.0001
764 RETCHING 3 0.0001
765 DIZZINESS 70 0.0001
766 SUBDURAL HAEMATOMA 2 0.0001
767 ANGINA PECTORIS 4 0.0001
768 DYSPNOEA 79 0.0001
769 DEEP VEIN THROMBOSIS 9 0.0001
770 WEIGHT INCREASED 31 0.0001
771 FAECES DISCOLOURED 3 0.0001
772 FALL 46 0.0001
773 MENTAL DISORDER 6 0.0001
774 INJECTION SITE HAEMATOMA 2 0.0001
775 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
776 CRYING 5 0.0001
777 LIVER FUNCTION TEST ABNORMAL 4 0.0001
778 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
779 FLUID OVERLOAD 2 0.0001
780 THERAPY CESSATION 7 0.0001
781 MELAENA 3 0.0001
782 ANGIOEDEMA 6 0.0001
783 ABDOMINAL DISTENSION 14 0.0001
784 ORAL PAIN 3 0.0001
785 CHROMATURIA 3 0.0001
786 HYPOAESTHESIA ORAL 2 0.0001
787 UNEVALUABLE EVENT 10 0.0001
788 MUSCULAR WEAKNESS 15 0.0001
789 VERTIGO 8 0.0001
790 INJECTION SITE RASH 4 0.0001
791 PYREXIA 45 0.0001
792 EJECTION FRACTION DECREASED 2 0.0001
793 BONE DENSITY DECREASED 4 0.0001
794 ARRHYTHMIA 6 0.0001
795 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
796 HEAD INJURY 4 0.0001
797 PNEUMOTHORAX 2 0.0001
798 MOOD SWINGS 4 0.0001
799 MALAISE 55 0.0001
800 URTICARIA 21 0.0001
801 HYPOTHYROIDISM 4 0.0001
802 SENSORY DISTURBANCE 2 0.0001
803 HYPERHIDROSIS 16 0.0001
804 DYSKINESIA 5 0.0001
805 ASTHENIA 46 0.0001
806 CHOLELITHIASIS 4 0.0001
807 METASTASES TO BONE 2 0.0001
808 LETHARGY 7 0.0001
809 EYE DISORDER 4 0.0001
810 OSTEONECROSIS OF JAW 3 0.0001
811 DYSGEUSIA 9 0.0001
812 AGEUSIA 3 0.0001
813 VIRAL INFECTION 4 0.0001
814 GAIT DISTURBANCE 23 0.0001
815 SYNCOPE 12 0.0001
816 POLLAKIURIA 5 0.0001
817 DYSPHONIA 7 0.0001
818 INJECTION SITE PRURITUS 8 0.0001
819 EYE PRURITUS 4 0.0001
820 PERICARDITIS 2 0.0001
821 RENAL IMPAIRMENT 10 0.0001
822 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
823 TYPE 2 DIABETES MELLITUS 4 0.0001
824 FACE OEDEMA 2 0.0001
825 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
826 DRUG RESISTANCE 3 0.0001
827 VISION BLURRED 16 0.0001
828 UNRESPONSIVE TO STIMULI 3 0.0001
829 MUSCULOSKELETAL DISCOMFORT 2 0.0001
830 DYSPHAGIA 11 0.0001
831 EXPOSURE VIA SKIN CONTACT 3 0.0001
832 NIGHTMARE 4 0.0001
833 DEVICE LEAKAGE 5 0.0001
834 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
835 HAEMORRHAGE 12 0.0001
836 RHEUMATOID ARTHRITIS 13 0.0001
837 SYRINGE ISSUE 2 0.0001
838 HYPERKALAEMIA 4 0.0001
839 GASTRITIS 3 0.0001
840 COLD SWEAT 2 0.0001
841 HEAD DISCOMFORT 2 0.0001
842 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
843 TOOTHACHE 2 0.0001
844 OSTEOMYELITIS 2 0.0001
845 LIMB INJURY 3 0.0001
846 CONSTIPATION 24 0.0001
847 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
848 HYPERGLYCAEMIA 4 0.0001
849 MUSCLE SPASMS 20 0.0001
850 ANAPHYLACTIC REACTION 6 0.0001
851 BLOOD GLUCOSE ABNORMAL 2 0.0001
852 DECREASED APPETITE 25 0.0001
853 SEPSIS 12 0.0001
854 HEPATIC STEATOSIS 2 0.0001
855 THINKING ABNORMAL 2 0.0001
856 BLOOD CHOLESTEROL INCREASED 5 0.0001
857 DRUG INTERACTION 17 0.0001
858 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
859 INTESTINAL OBSTRUCTION 4 0.0001
860 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
861 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
862 FEELING JITTERY 2 0.0001
863 INCREASED APPETITE 2 0.0001
864 MULTIPLE SCLEROSIS 5 0.0001
865 PRODUCT SUBSTITUTION ISSUE 6 0.0001
866 ERUCTATION 2 0.0001
867 NEEDLE ISSUE 3 0.0001
868 ACUTE MYOCARDIAL INFARCTION 3 0.0001
869 DISABILITY 2 0.0001
870 RENAL INJURY 3 0.0001
871 HEART RATE INCREASED 10 0.0001
872 HYPOAESTHESIA 15 0.0001
873 PREGNANCY 2 0.0001
874 SPINAL FRACTURE 2 0.0001
875 ANAEMIA 19 0.0001
876 CARDIAC FAILURE CONGESTIVE 8 0.0001
877 INJURY 7 0.0001
878 STOMATITIS 6 0.0001
879 ILL-DEFINED DISORDER 6 0.0001
880 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
881 CHEST DISCOMFORT 10 0.0001
882 MYOCARDIAL INFARCTION 17 0.0001
883 HAEMOGLOBIN DECREASED 10 0.0001
884 RIB FRACTURE 2 0.0001
885 TOOTH LOSS 2 0.0001
886 BLOOD GLUCOSE INCREASED 18 0.0001
887 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
888 PLATELET COUNT DECREASED 10 0.0001
889 JOINT INJURY 2 0.0001
890 EPISTAXIS 7 0.0001
891 HIP FRACTURE 3 0.0001
892 INCORRECT DOSE ADMINISTERED 21 0.0001
893 PRODUCT DISPENSING ERROR 2 0.0001
894 INFUSION RELATED REACTION 6 0.0001
895 VISUAL ACUITY REDUCED 3 0.0001
896 URINARY RETENTION 3 0.0001
897 HEPATOTOXICITY 2 0.0001
898 CARDIAC FAILURE 7 0.0001
899 EYE IRRITATION 5 0.0001
900 CONFUSIONAL STATE 14 0.0001
901 PERICARDIAL EFFUSION 2 0.0001
902 RENAL DISORDER 4 0.0001
903 BONE PAIN 5 0.0001
904 CEREBRAL HAEMORRHAGE 3 0.0001
905 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
906 BLOOD GLUCOSE DECREASED 4 0.0001
907 HEPATIC CANCER 2 0.0001
908 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
909 INTERSTITIAL LUNG DISEASE 4 0.0001
910 DEHYDRATION 11 0.0001
911 PRESYNCOPE 2 0.0001
912 BALANCE DISORDER 7 0.0001
913 ABASIA 2 0.0001
914 INTENTIONAL PRODUCT MISUSE 7 0.0001
915 HOT FLUSH 6 0.0001
916 TACHYCARDIA 7 0.0001
917 FLUID RETENTION 4 0.0001
918 INJECTION SITE SWELLING 6 0.0001
919 ANAPHYLACTIC SHOCK 2 0.0001
920 MUCOSAL INFLAMMATION 2 0.0001
921 SEDATION 2 0.0001
922 DISORIENTATION 3 0.0001
923 PULMONARY EMBOLISM 7 0.0001
924 MOOD ALTERED 2 0.0001
925 CARDIAC ARREST 6 0.0001
926 RESPIRATORY ARREST 2 0.0001
927 TREMOR 12 0.0001
928 MENTAL STATUS CHANGES 2 0.0001
929 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
930 HAEMOPTYSIS 2 0.0001
931 EYE PAIN 4 0.0001
932 ASTHMA 8 0.0001
933 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
934 RESPIRATORY FAILURE 5 0.0001
935 UNDERDOSE 5 0.0001
936 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
937 PULMONARY OEDEMA 3 0.0001
938 THROAT IRRITATION 3 0.0001
939 IRRITABILITY 4 0.0001
940 BLOOD POTASSIUM DECREASED 2 0.0001
941 PRODUCT QUALITY ISSUE 9 0.0001
942 EPILEPSY 2 0.0001
943 DRUG ADMINISTRATION ERROR 2 0.0001
944 HOSPITALISATION 10 0.0001
945 HYPOKALAEMIA 3 0.0001
946 EMOTIONAL DISORDER 2 0.0001
947 EXPOSURE DURING PREGNANCY 4 0.0001
948 NERVOUS SYSTEM DISORDER 2 0.0001
949 DISEASE RECURRENCE 3 0.0001
950 SOMNOLENCE 12 0.0001
951 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
952 DISEASE PROGRESSION 7 0.0001
953 HAEMATURIA 2 0.0001
954 SPEECH DISORDER 3 0.0001
955 PANCREATITIS 3 0.0001
956 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
957 ACCIDENTAL OVERDOSE 2 0.0001
958 PANCYTOPENIA 3 0.0001
959 THROMBOCYTOPENIA 6 0.0001
960 OXYGEN SATURATION DECREASED 3 0.0001
961 HYPONATRAEMIA 3 0.0001
962 CEREBROVASCULAR ACCIDENT 9 0.0001
963 DYSPNOEA EXERTIONAL 2 0.0001
964 HALLUCINATION 4 0.0001
965 FLATULENCE 3 0.0001
966 SEIZURE 6 0.0001
967 PLASMA CELL MYELOMA 2 0.0001
968 BLADDER CANCER 3 0.0001
969 PROSTATE CANCER 4 0.0000
970 EXTRA DOSE ADMINISTERED 2 0.0000
971 LUNG NEOPLASM MALIGNANT 2 0.0000
972 OVERDOSE 10 0.0000
973 SEPTIC SHOCK 2 0.0000
974 BLOOD PRESSURE DECREASED 3 0.0000
975 HYPOTENSION 9 0.0000
976 COLITIS ULCERATIVE 2 0.0000
977 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
978 HYPOGLYCAEMIA 2 0.0000
979 LUNG DISORDER 2 0.0000
980 NO ADVERSE EVENT 7 0.0000
981 DISTURBANCE IN ATTENTION 2 0.0000
982 NEUTROPENIA 5 0.0000
983 DEATH 30 0.0000
984 DRUG WITHDRAWAL SYNDROME 3 0.0000
985 SUICIDE ATTEMPT 2 0.0000
986 PLEURAL EFFUSION 2 0.0000
987 BREAST CANCER 3 0.0000
988 BLOOD CREATININE INCREASED 2 0.0000
989 DRUG DOSE OMISSION BY DEVICE 2 0.0000
990 TOXICITY TO VARIOUS AGENTS 4 0.0000
991 DRUG DEPENDENCE 3 0.0000